In addition, although pharmacological research on PRX and 3-MPR is relatively rare, PRX showed great potential in suppressing tumor growth as a prodrug [20], and 3-MPR exhibited protective effects on cerebral ischemia-reperfusion injuries [21]. The gene discussed is PRX; the disease is brain ischemia.